1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Clinical Trial Imaging Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Clinical Trial Imaging Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biopharmaceutical Industries
- 5.1.2 Spur in Number of CROS Offering Medical Imaging Services
5.2 Market Opportunities
- 5.2.1 In-Silico Imaging Clinical Trials
5.3 Future Trends
- 5.3.1 Al-Driven Clinical Trials
5.4 Impact of Drivers and Restraints
6. North America Clinical Trial Imaging Market Regional Analysis
6.1 North America Clinical Trial Imaging Market Overview
6.2 North America Clinical Trial Imaging Market Revenue 2021-2028 (US$ Million)
6.3 North America Clinical Trial Imaging Market Forecast Analysis
7. North America Clinical Trial Imaging Market Analysis – by Modality
7.1 Tomography
- 7.1.1 Overview
- 7.1.2 Tomography: North America Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Magnetic Resonance Imaging
- 7.2.1 Overview
- 7.2.2 Magnetic Resonance Imaging: North America Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Ultrasound
- 7.3.1 Overview
- 7.3.2 Ultrasound: North America Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Positron Emission Tomography
- 7.4.1 Overview
- 7.4.2 Positron Emission Tomography: North America Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.5 X-Ray
- 7.5.1 Overview
- 7.5.2 X-Ray: North America Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Echocardiography
- 7.6.1 Overview
- 7.6.2 Echocardiography: North America Clinical Trial Imaging Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Clinical Trial Imaging Market Analysis – by Offering
8.1 Operational Imaging Services
- 8.1.1 Overview
- 8.1.2 Operational Imaging Services: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Imaging Software
- 8.2.1 Overview
- 8.2.2 Imaging Software: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Read Analysis Services
- 8.3.1 Overview
- 8.3.2 Read Analysis Services: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Trial Design and Consulting Services
- 8.4.1 Overview
- 8.4.2 Trial Design and Consulting Services: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Clinical Trial Imaging Market Analysis – by End User
9.1 Contract Research Organizations
- 9.1.1 Overview
- 9.1.2 Trial Design and Consulting Services: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Pharmaceutical and Biotechnology Companies
- 9.2.1 Overview
- 9.2.2 Trial Design and Consulting Services: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Academic and Research Institutes
- 9.3.1 Overview
- 9.3.2 Trial Design and Consulting Services: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Trial Design and Consulting Services: North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Clinical Trial Imaging Market – North America Analysis
10.1 North America
- 10.1.1 North America Clinical Trial Imaging Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.1.1.1 North America Clinical Trial Imaging Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Clinical Trial Imaging Market Breakdown, by Modality
- 10.1.1.1.2 US: North America Clinical Trial Imaging Market Breakdown, by Offering
- 10.1.1.1.3 US: North America Clinical Trial Imaging Market Breakdown, by End User
- 10.1.1.2 Canada:
North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Clinical Trial Imaging Market Breakdown, by Modality
- 10.1.1.2.2 Canada: North America Clinical Trial Imaging Market Breakdown, by Offering
- 10.1.1.2.3 Canada: North America Clinical Trial Imaging Market Breakdown, by End User
- 10.1.1.3 Mexico :
North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Clinical Trial Imaging Market Breakdown, by Modality
- 10.1.1.3.2 Mexico : North America Clinical Trial Imaging Market Breakdown, by Offering
- 10.1.1.3.3 Mexico : North America Clinical Trial Imaging Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Clinical Trial Imaging Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 BioTelemetry Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Calyx Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 eResearch Technology Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 ICON PLC
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 IXICO plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medical Metrics Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Medpace Holdings Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 VIDA Diagnostics Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 WCG Clinical Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Clinical Trial Imaging Market
